Guidelines for Free Light Chain Measurements - PowerPoint PPT Presentation

1 / 15
About This Presentation
Title:

Guidelines for Free Light Chain Measurements

Description:

On behalf of the International Myeloma Working Group ... Antigen Excess (Aberrant Low) Polymerization (Aberrant High) Lot-Lot Variation ... – PowerPoint PPT presentation

Number of Views:163
Avg rating:3.0/5.0
Slides: 16
Provided by: claire99
Category:

less

Transcript and Presenter's Notes

Title: Guidelines for Free Light Chain Measurements


1
Guidelines for Free Light Chain Measurements
5th International Symposium on Clinical
Applications of
Serum-Free Light Chain Analysis
Brian G.M. Durie, M.D. On behalf of the
International Myeloma Working Group
Friday, Sept. 19, 2008
2
Are these sheep up for contract renewal?
3
Overview Summary of Free Light Chain Test
  • Serum Test (not urine)
  • More sensitive than SPE or IFE
  • Used for
  • Diagnosis
  • Prognosis
  • Response Assessment
  • Disease Monitoring
  • Practical caveats important
  • Cost effective and available

Dispenzieri et al. Leukemia, In Press 2008
4
Diagnosis
Question of Monoclonal Plasma Cell Disorder
5
Is 24hr Urine UPEP/IFE Required?
If Urine IFE Positive
  • sFLC Ratio Abnormal 86
  • sIFE Abnormal 93.5
  • One or Both Abnormal 99.5

6
Prognosis
  • MGUS
  • Solitary Plasmacytoma
  • Smoldering Myeloma
  • Active Myeloma
  • Amyloidosis
  • Be Aware of Other Testing
  • Solitary ? - PET-CT Helpful
  • Amyloid Cardiac Troponin

7
Risk of Progression in MGUS
  • IgG lt 1.5 gm/dl M-spike

Low Risk
  • Normal Freelite Ratio

High Risk
  • Not IgG
  • Spike 1.5gm/dl
  • Abnormal Ratio

8
Solitary Plasmacytoma and Smoldering Myeloma
Mayo data sets
9
TT3 Inferior Survival with Top-Tertile SFLC
Level at Baseline
Impact of Serum Free Light Chain (SFLC)
10
Response Assessment
  • Oligo secretory YES
  • Light Chain Only Maybe
  • Intact Immunoglobulin Maybe
  • Amyloidosis YES

11
Current Recommendations for Response Assessment
  • Routine Use
  • Oligo Secretory
  • Amyloidosis
  • Also all patients to assess
  • Stringent CR (sCR)

12
6 Mos. Earlier Indication of Relapse Than IFE
, ( mg/L)
6-mo Earlier Indication of Relapse
Mosbauer et al. Haematologica 200792275-276
13
Caveats and Cautions
  • Always double-check units (mg/l mg/dl)
  • Consider
  • Antigen Excess (Aberrant Low)
  • Polymerization (Aberrant High)
  • Lot-Lot Variation
  • Non-Linear Dilution
  • Impact of Renal Dysfunction
  • Impact of Ongoing Treatment

14
Value of sFLC
  • Diverse Uses
  • Readily Available
  • Cheap
  • Even doctors can learn how to interpret results!

15
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com